Search | ECR Journal

European Cardiology Review

Journal Impact Factor: 3.6

Back to Main Menu

View all platforms

Content for healthcare professionals only

Search results

Obicetrapib Lowers LDL-C in Familial Hypercholesterolemia

News

Added: 2 months ago Source: Radcliffe CVRM

For patients with heterozygous familial hypercholesterolemia (HeFH), achieving adequate low-density lipoprotein cholesterol (LDL-C) lowering remains a significant challenge. New results from the BROOKLYN trial suggest that the investigational agent obicetrapib could be an effective add-on therapy for this high-risk population.¹Mechanism of ActionObicetrapib is a highly selective cholesteryl ester… View more

Cardiovascular Kidney Metabolic

Heart Failure

Danielle Belardo

Author

Job title: Director of Preventive Cardiology & Co-Director of Research and Education

Personal History Dr Danielle Belardo is a New Yorker who relocated to Philadelphia after college to start her medical career.1 She is now a Preventive Cardiologist based in Newport Beach, California.2 In college, she started volunteering at the Alzheimer’s Association and got involved with the Leukemia & Lymphoma Society’s program to raise funds for the pediatric oncology unit at DuPont… View more

Lipid-lowering Therapies and Lp(a)

Review Article

Author(s): Stephen Nicholls , Adam J Nelson Added: 2 weeks ago

Prevention & Chronic Conditions

Vanguard AG

Supplier

As an innovative technology partner, VANGUARD supports hospitals with sustainable solutions providing improved quality and efficiency. VANGUARD is a manufacturer of medical devices and market leader in the validated special reprocessing of complex medical devices in Europe. In addition, the company is the German market leader in the field of all round system solutions for the supply of sterile… View more